Literature DB >> 20560288

Lymphangioleiomyomatosis: a study of 72 patients from the Spanish registry.

E Antón1, A Casanova, A Xaubet, A Román, V Villena, M C Montero, M Molina-Molina, E Pérez-Sánchez, A Sueiro, F Morell, R M Girón, J Ancochea.   

Abstract

BACKGROUND: Pulmonary lymphangioleiomyomatosis (LAM) is a rare lung disease that almost exclusively affects young women of childbearing age. The true incidence and prevalence of LAM are unknown. This study was conducted to evaluate the characteristics of lymphangioleiomyomatosis in Spain.
METHODS: Over a 2-year period, a questionnaire designed for this study was collected. This questionnaire included sociodemograhic, clinical, radiological and functional data. Information about the study and this questionnaire were both sent by e-mail to all the participants of the interstitial disease registry of 2004.
RESULTS: Seventy-two patients, all of whom were women, were included in the registry, with a mean age of 44.56 +/- 11.1 yr. Sixty-three patients (87.5%) presented the sporadic LAM and 9 (12.5%) presented LAM associated with tuberous sclerosis (LAM-TS). LAM diagnosis was confirmed with an open lung biopsy in 57 patients (79.2%) and was performed with thoracic HRCT compatible with LAM diagnosis in the other 15 cases. The most frequent symptom was dyspnoea (90%) followed by cough (44.4%). Almost 40% of patients presented renal angiomyolipomas in the study and the most frequent spirometric pattern was obstructive in more than half of the patients. Most patients with LAM-TS (88.8%) had renal angiomyolipomas compared with 31.7% in the sporadic LAM group.
CONCLUSION: The characteristics of the Spanish population affected with LAM are similar to those of other countries. Most patients were symptomatic, had a history of previous pneumothorax and presented abnormal radiological findings and pulmonary function tests.

Entities:  

Mesh:

Year:  2009        PMID: 20560288

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  3 in total

1.  A practical approach to cystic lung disease on HRCT.

Authors:  Peter Beddy; Judith Babar; Anand Devaraj
Journal:  Insights Imaging       Date:  2010-11-12

2.  Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.

Authors:  Gorka Ruiz de Garibay; Carmen Herranz; Alicia Llorente; Jacopo Boni; Jordi Serra-Musach; Francesca Mateo; Helena Aguilar; Laia Gómez-Baldó; Anna Petit; August Vidal; Fina Climent; Javier Hernández-Losa; Álex Cordero; Eva González-Suárez; José Vicente Sánchez-Mut; Manel Esteller; Roger Llatjós; Mar Varela; José Ignacio López; Nadia García; Ana I Extremera; Anna Gumà; Raúl Ortega; María Jesús Plà; Adela Fernández; Sònia Pernas; Catalina Falo; Idoia Morilla; Miriam Campos; Miguel Gil; Antonio Román; María Molina-Molina; Piedad Ussetti; Rosalía Laporta; Claudia Valenzuela; Julio Ancochea; Antoni Xaubet; Álvaro Casanova; Miguel Angel Pujana
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

Review 3.  High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia.

Authors:  Uchenna Unachukwu; Kiran Chada; Jeanine D'Armiento
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.